Magnite (MGNI) Rule 144: 14,461 RSU shares slated for sale via Morgan Stanley
Rhea-AI Filing Summary
Magnite, Inc. (MGNI) Rule 144 notice: The filer proposes to sell 14,461 shares of common stock, to be handled by Morgan Stanley Smith Barney LLC, with an approximate aggregate market value of $342,725.70 and an approximate sale date of 08/18/2025 on NASDAQ. The securities were acquired as restricted stock units from the issuer on 08/15/2025 and the stated payment/nature is equity compensation. The filing also discloses an earlier sale by Sean Buckley of 9,692 shares on 05/16/2025 for $152,491.04. By signing, the seller represents they are not aware of any undisclosed material adverse information about the issuer.
Positive
- None.
Negative
- None.
Insights
TL;DR: Insider plans a modest sale of restricted stock units totaling $342.7k; prior sale of 9,692 shares occurred in May for $152.5k.
The notice shows a proposed sale of 14,461 common shares derived from restricted stock units granted by the issuer on 08/15/2025. The broker is Morgan Stanley Smith Barney and the execution is targeted for NASDAQ on 08/18/2025. The disclosed aggregate value of $342,725.70 implies an average implied price consistent with the filer’s recent transactions. A prior sale by Sean Buckley of 9,692 shares on 05/16/2025 generated $152,491.04, which provides a recent liquidity event for the same account. For investors, these are routine Rule 144 transactions converting compensated equity into marketable shares and do not, by themselves, convey new operational or financial information about Magnite.
TL;DR: This is a standard compliance filing documenting insider sale mechanics and the seller’s attestation about material non-public information.
The form documents compliance with Rule 144 disclosure requirements for restricted stock units issued by the company and intended market sale details, including broker, share count, and estimated value. The seller’s signed attestation that no undisclosed material adverse information exists is a standard legal representation. There is no indication of an executed trading plan or 10b5-1 adoption date in the remarks. From a governance perspective, the filing records transparency around insider liquidity but does not indicate governance changes or issues.